Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials

Kevin Wing, Elizabeth Williamson, James R. Carpenter, Lesley Wise, Sebastian Schneeweiss, Liam Smeeth, Jennifer K. Quint, Ian Douglas
European Respiratory Journal 2021 57: 2001586; DOI: 10.1183/13993003.01586-2020
Kevin Wing
1Dept of Non-communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Williamson
2Dept of Medical Statistics, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elizabeth Williamson
James R. Carpenter
2Dept of Medical Statistics, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lesley Wise
1Dept of Non-communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastian Schneeweiss
3Dept of Epidemiology, Harvard Medical School, Boston, MA, USA
4Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liam Smeeth
1Dept of Non-communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer K. Quint
5National Heart and Lung Institute, Imperial College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jennifer K. Quint
Ian Douglas
1Dept of Non-communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 57 no. 3
DOI 
https://doi.org/10.1183/13993003.01586-2020
PubMed 
33093119

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Received May 5, 2020
  • Accepted September 26, 2020
  • Published online March 25, 2021.

Article Versions

  • previous version (October 22, 2020 - 07:50).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright ©ERS 2021

Author Information

  1. Kevin Wing1,
  2. Elizabeth Williamson2,
  3. James R. Carpenter2,
  4. Lesley Wise1,
  5. Sebastian Schneeweiss3,4,
  6. Liam Smeeth1,
  7. Jennifer K. Quint5 and
  8. Ian Douglas1
  1. 1Dept of Non-communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
  2. 2Dept of Medical Statistics, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
  3. 3Dept of Epidemiology, Harvard Medical School, Boston, MA, USA
  4. 4Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital, Boston, MA, USA
  5. 5National Heart and Lung Institute, Imperial College London, London, UK
  1. Kevin Wing, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. E-mail: kevin.wing{at}lshtm.ac.uk
View Full Text

Funding

  • National Institute for Health Research

    15/80/28

Article usage

Article usage: October 2020 to May 2022

AbstractFullPdf
Oct 20203994138
Nov 20203613648
Dec 20204662323
Jan 2021141712
Feb 2021142712
Mar 202184810369
Apr 20218506050
May 20215882415
Jun 20217742441
Jul 20213311651
Aug 2021459744
Sep 2021267137
Oct 20214014342
Nov 2021316052
Dec 202127353
Jan 202204617
Feb 2022138330
Mar 20221612118
Apr 2022119431
May 2022177540

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 57 Issue 3 Table of Contents
European Respiratory Journal: 57 (3)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials
Kevin Wing, Elizabeth Williamson, James R. Carpenter, Lesley Wise, Sebastian Schneeweiss, Liam Smeeth, Jennifer K. Quint, Ian Douglas
European Respiratory Journal Mar 2021, 57 (3) 2001586; DOI: 10.1183/13993003.01586-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials
Kevin Wing, Elizabeth Williamson, James R. Carpenter, Lesley Wise, Sebastian Schneeweiss, Liam Smeeth, Jennifer K. Quint, Ian Douglas
European Respiratory Journal Mar 2021, 57 (3) 2001586; DOI: 10.1183/13993003.01586-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Materials and methods
    • Results
    • Discussion
    • Supplementary material
    • Shareable PDF
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original Articles

  • Systematic assessment of respiratory health in illness susceptible athletes
  • Identifying early PAH biomarkers in systemic sclerosis
  • Viable virus aerosol propagation by PAP circuit leak
Show more Original Articles

COPD

  • Use of singing for lung health in COPD
  • Response to exercise training and withdrawal in COPD
  • A phase 2a crossover trial in COPD of the bronchodilator navafenterol
Show more COPD

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society